Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5529791 | BIOVAIL | Extended release form of diltiazem |
Jun, 2013
(10 years ago) |
Drugs and Companies using DILTIAZEM HYDROCHLORIDE ingredient
Market Authorisation Date: 28 January, 2000
Treatment: NA
Dosage: CAPSULE, EXTENDED RELEASE;ORAL